Androtriol

安脑三醇

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameAndrotriol
Drug Alias NameYC-6
ClassificationSmall molecules > Steroids
Mechanisms of ActionVoltage-gated calcium channel blockersGlutamate [NMDA] receptor antagonists
TargetsVoltage-gated calcium channelGlutamate [NMDA] receptor
Therapy Area/IndicationsIschemic StrokeStrokeCerebral Hemorrhage +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSun Yat-Sen University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Tiantan Hospital, Capital Medical UniversityGuangzhou Cellprotek Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeStrokeCerebral Hemorrhage +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A